BioLineRx Ltd. (BLRX)
TASE
1.50
-0.10 (-6.25%)
Real-time Data
06:59 AM
Day's Range
1.501.60
52 wk Range
1.102.40
Financial Statements - BLRX - BioLineRx Ltd.
Revenue
1.18M▼ 95.9%
Net Income
-2.02M▲ 78.0%Net Margin -171.7%
EBITDA
-9.19M▲ 33.6%
Free Cash Flow
-8.10M▲ 81.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.18M | 28.94M | 4.80M | 0 | 0 | 0 |
| Cost of Goods | 230K | 9.26M | 3.69M | 0 | 0 | - |
| Gross Profit | 950K | 19.67M | 1.10M | 0 | 0 | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -10.28M | -19.15M | -42.99M | -29.15M | -24.77M | -22.92M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 8.41M | 17.23M | -17.46M | 5.32M | -1.54M | -5.83M |
| Pre Tax Income | -2.02M | -9.22M | -60.61M | -24.95M | -27.05M | -30.02M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -2.02M | -9.22M | -60.61M | -24.95M | -27.05M | -30.02M |
| EPS Basic | 0 | -0.01 | -0.06 | -0.03 | -0.04 | -0.12 |
| EPS Diluted | 0 | -0.01 | -0.06 | -0.03 | -0.04 | -0.12 |
| Basic Shares Outstanding | 2.46B | 1.19B | 260.82M | 216.41M | 185.36M | 70.69M |
| Diluted Shares Outstanding | 2.46B | 1.19B | 260.82M | 216.41M | 185.36M | 70.69M |
| Ebit | -775K | -147K | -58.47M | -23.16M | -26.07M | -28.55M |
| Ebitda | -9.19M | -13.84M | -39.39M | -28.59M | -23.71M | -22.33M |
| Net Income Continuous Operations | -2.02M | -9.22M | -60.61M | -24.95M | -27.05M | -30.02M |
| Minority Interests | 851K | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
